• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估超重或肥胖儿童和青少年代谢功能障碍相关脂肪性肝病的全球患病率:系统评价和荟萃分析。

Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis.

机构信息

Department of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, China.

Laboratory of Thyroid and Parathyroid Diseases, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

出版信息

Int J Public Health. 2021 Oct 6;66:1604371. doi: 10.3389/ijph.2021.1604371. eCollection 2021.

DOI:10.3389/ijph.2021.1604371
PMID:34690666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8527331/
Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new terminology updated from non-alcoholic fatty liver disease (NAFLD). We aim to estimate the global prevalence of MAFLD in overweight or obese children and adolescents, by repurposing existing data on fatty liver disease. We screened relevant articles published up to December 2020. Pooled prevalence was calculated using Logit transformations. Our search returned 35,441 records, of which 156 studies fulfilled the inclusion criteria. The overall prevalence of MAFLD was 33.78% in the general population and 44.94% in a special population based on child obesity clinics, regardless of the diagnostic techniques. For subgroup analysis, MAFLD prevalence was significantly higher in boys compared to girls (36.05 vs. 26.84% in the general population; 50.20 vs. 35.34% in the child obesity clinics-based population). Interestingly, based on study source, the pooled prevalence of MAFLD was 1.5-fold higher in other "fatty liver disease" studies compared to the classical "NAFLD" studies in the general population. MAFLD is highly prevalent in overweight or obese children and adolescents. Raising awareness and urgent actions are warranted to control the MAFLD pandemic across the globe.

摘要

代谢相关脂肪性肝病(MAFLD)是从非酒精性脂肪性肝病(NAFLD)更新的一个新术语。我们旨在通过重新利用现有的关于脂肪肝疾病的数据来估计超重或肥胖儿童和青少年中 MAFLD 的全球患病率。我们筛选了截至 2020 年 12 月发表的相关文章。使用 Logit 转换计算汇总患病率。我们的搜索返回了 35441 条记录,其中 156 项研究符合纳入标准。无论诊断技术如何,普通人群中 MAFLD 的总体患病率为 33.78%,特殊人群(基于儿童肥胖诊所)中 MAFLD 的患病率为 44.94%。对于亚组分析,与女孩相比,男孩中 MAFLD 的患病率明显更高(普通人群中为 36.05%比 26.84%;基于儿童肥胖诊所的人群中为 50.20%比 35.34%)。有趣的是,根据研究来源,在普通人群中,与经典的“NAFLD”研究相比,其他“脂肪肝疾病”研究中 MAFLD 的汇总患病率高 1.5 倍。MAFLD 在超重或肥胖的儿童和青少年中患病率很高。全球范围内需要提高认识并采取紧急行动来控制 MAFLD 大流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e32/8527331/dd08f9b0b777/ijph-66-1604371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e32/8527331/9781e0634bb5/ijph-66-1604371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e32/8527331/caebb63ec40f/ijph-66-1604371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e32/8527331/dd08f9b0b777/ijph-66-1604371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e32/8527331/9781e0634bb5/ijph-66-1604371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e32/8527331/caebb63ec40f/ijph-66-1604371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e32/8527331/dd08f9b0b777/ijph-66-1604371-g003.jpg

相似文献

1
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis.评估超重或肥胖儿童和青少年代谢功能障碍相关脂肪性肝病的全球患病率:系统评价和荟萃分析。
Int J Public Health. 2021 Oct 6;66:1604371. doi: 10.3389/ijph.2021.1604371. eCollection 2021.
2
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults.估算超重或肥胖成年人代谢功能障碍相关脂肪性肝病的全球患病率。
Clin Gastroenterol Hepatol. 2022 Mar;20(3):e573-e582. doi: 10.1016/j.cgh.2021.02.030. Epub 2021 Feb 20.
3
Prevalence and associated factors of metabolic-associated fatty liver disease in overweight Finnish children and adolescents.超重芬兰儿童和青少年代谢相关脂肪性肝病的流行情况及其相关因素。
Front Endocrinol (Lausanne). 2023 Jun 20;14:1090344. doi: 10.3389/fendo.2023.1090344. eCollection 2023.
4
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives.儿童代谢(功能)相关脂肪性肝病:当前认识与未来展望。
Hepatol Int. 2024 Oct;18(Suppl 2):873-883. doi: 10.1007/s12072-024-10691-5. Epub 2024 Jun 16.
5
Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.代谢相关脂肪性肝病与中国成年人死亡风险的前瞻性队列研究。
J Clin Endocrinol Metab. 2022 Jan 18;107(2):e745-e755. doi: 10.1210/clinem/dgab644.
6
A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health.代谢相关脂肪性肝病(MAFLD)在全球范围内及墨西哥的儿童和青少年中流行率不断上升的研究综述及其对公共卫生的影响。
Med Sci Monit. 2021 Aug 30;27:e934134. doi: 10.12659/MSM.934134.
7
Maternal gestational hypertension, smoking and pre-eclampsia are associated with metabolic dysfunction-associated fatty liver disease in overweight offspring.母体妊娠期高血压、吸烟和子痫前期与超重后代代谢功能障碍相关脂肪性肝病有关。
Acta Obstet Gynecol Scand. 2024 Jun;103(6):1183-1191. doi: 10.1111/aogs.14816. Epub 2024 Mar 3.
8
Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study.澳大利亚区域性队列研究中,将非酒精性脂肪性肝病更名为代谢相关性脂肪性肝病的影响:一项前瞻性基于人群的研究结果。
J Gastroenterol Hepatol. 2022 Feb;37(2):395-403. doi: 10.1111/jgh.15723. Epub 2021 Nov 4.
9
Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort.上海出生队列中青春期前儿童 MAFLD 的患病率和发病率及相关人体测量参数。
Hepatol Int. 2023 Dec;17(6):1416-1428. doi: 10.1007/s12072-023-10574-1. Epub 2023 Sep 20.
10
Associations of metal mixtures with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2003-2018.金属混合物与代谢相关脂肪性肝病和非酒精性脂肪性肝病的关联:NHANES 2003-2018。
Front Public Health. 2023 Mar 6;11:1133194. doi: 10.3389/fpubh.2023.1133194. eCollection 2023.

引用本文的文献

1
High Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents with Severe Obesity.重度肥胖儿童及青少年中代谢相关脂肪性肝病(MAFLD)的高患病率
J Clin Med. 2025 May 20;14(10):3565. doi: 10.3390/jcm14103565.
2
Apoptosis markers in children with metabolic-associated fatty liver disease: a preliminary study.代谢相关脂肪性肝病患儿的凋亡标志物:一项初步研究。
Prz Gastroenterol. 2025;20(1):41-47. doi: 10.5114/pg.2025.148527. Epub 2025 Mar 16.
3
Association of cardiovascular health metrics and metabolic associated fatty liver disease: Methodological limitations, and future directions.

本文引用的文献

1
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement.定义儿科代谢(功能)相关脂肪性肝病:国际专家共识声明。
Lancet Gastroenterol Hepatol. 2021 Oct;6(10):864-873. doi: 10.1016/S2468-1253(21)00183-7. Epub 2021 Aug 6.
2
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults.估算超重或肥胖成年人代谢功能障碍相关脂肪性肝病的全球患病率。
Clin Gastroenterol Hepatol. 2022 Mar;20(3):e573-e582. doi: 10.1016/j.cgh.2021.02.030. Epub 2021 Feb 20.
3
Metabolic dysfunction-associated fatty liver disease: a new clearer nomenclature with positive diagnostic criteria.
心血管健康指标与代谢相关脂肪性肝病的关联:方法学局限性及未来方向。
World J Hepatol. 2025 Mar 27;17(3):105635. doi: 10.4254/wjh.v17.i3.105635.
4
Dietary and lifestyle indices for hyperinsulinemia and odds of MAFLD in overweight and obese children and adolescents.超重和肥胖儿童及青少年中高胰岛素血症的饮食和生活方式指数与MAFLD的发生几率
Sci Rep. 2025 Feb 6;15(1):4465. doi: 10.1038/s41598-025-88969-3.
5
Potential alternative and novel biomarkers for paediatric MAFLD: exploratory evidence from a Chinese cohort.儿童代谢功能障碍相关脂肪性肝病的潜在替代生物标志物和新型生物标志物:来自中国队列的探索性证据。
BMC Gastroenterol. 2025 Jan 22;25(1):28. doi: 10.1186/s12876-025-03619-2.
6
Converging Pathways between Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Diabetes in Children.代谢功能障碍相关脂肪性肝病(MASLD)与儿童糖尿病之间的交汇途径。
Int J Mol Sci. 2024 Sep 14;25(18):9924. doi: 10.3390/ijms25189924.
7
Sex- and gender-based medicine in pediatric nutrition.儿科营养中的性别医学。
Ital J Pediatr. 2024 Sep 2;50(1):159. doi: 10.1186/s13052-024-01734-6.
8
Establish a noninvasive model to screen metabolic dysfunction-associated steatotic liver disease in children aged 6-14 years in China and its applications in high-obesity-risk countries and regions.建立一种非侵入性模型,用于筛查中国6至14岁儿童的代谢功能障碍相关脂肪性肝病及其在高肥胖风险国家和地区的应用。
Lancet Reg Health West Pac. 2024 Jul 25;49:101150. doi: 10.1016/j.lanwpc.2024.101150. eCollection 2024 Aug.
9
Serum proteome signatures associated with liver steatosis in adolescents with obesity.与肥胖青少年肝脂肪变性相关的血清蛋白质组特征
J Endocrinol Invest. 2025 Jan;48(1):213-225. doi: 10.1007/s40618-024-02419-x. Epub 2024 Jul 17.
10
Interplay between metabolic dysfunction-associated fatty liver disease and renal function: An intriguing pediatric perspective.代谢功能障碍相关脂肪性肝病与肾功能之间的相互作用:一个有趣的儿科视角。
World J Gastroenterol. 2024 Apr 21;30(15):2081-2086. doi: 10.3748/wjg.v30.i15.2081.
代谢功能障碍相关脂肪性肝病:一种具有明确诊断标准的新命名法。
Acta Gastroenterol Belg. 2020 Oct-Dec;83(4):513-515.
4
A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD.一个缩写中的一个字母变化:从非酒精性脂肪性肝病 (NAFLD) 到代谢相关性脂肪性肝病 (MAFLD) 的信号、原因、承诺、挑战和前进步骤。
Expert Rev Gastroenterol Hepatol. 2021 Apr;15(4):345-352. doi: 10.1080/17474124.2021.1860019. Epub 2020 Dec 9.
5
MAFLD criteria overlooks a number of patients with severe steatosis: Is it clinically relevant?MAFLD标准忽视了许多患有严重脂肪变性的患者:这在临床上有相关性吗?
J Hepatol. 2020 Nov;73(5):1265-1267. doi: 10.1016/j.jhep.2020.06.016. Epub 2020 Aug 17.
6
From NAFLD to MAFLD: a "redefining" moment for fatty liver disease.从非酒精性脂肪性肝病到代谢相关脂肪性肝病:脂肪性肝病的一个“重新定义”时刻。
Chin Med J (Engl). 2020 Oct 5;133(19):2271-2273. doi: 10.1097/CM9.0000000000000981.
7
From NAFLD to MAFLD: Implications of a Premature Change in Terminology.从非酒精性脂肪性肝病到代谢相关脂肪性肝病:术语过早改变的影响。
Hepatology. 2021 Mar;73(3):1194-1198. doi: 10.1002/hep.31420. Epub 2021 Feb 6.
8
Comparison of MAFLD and NAFLD diagnostic criteria in real world.现实世界中MAFLD与NAFLD诊断标准的比较。
Liver Int. 2020 Sep;40(9):2082-2089. doi: 10.1111/liv.14548. Epub 2020 Jul 26.
9
From NAFLD to MAFLD: when pathophysiology succeeds.从非酒精性脂肪性肝病到代谢相关脂肪性肝病:病理生理学的成功转变
Nat Rev Gastroenterol Hepatol. 2020 Jul;17(7):387-388. doi: 10.1038/s41575-020-0316-6. Epub 2020 May 27.
10
From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 years.从非酒精性脂肪性肝病(NAFLD)到代谢相关脂肪性肝病(MAFLD):跨越40年的历程
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):695-696. doi: 10.1016/j.dsx.2020.05.019. Epub 2020 May 13.